Aprea Therapeutics, Inc. SEC filings APRE
Aprea Therapeutics, Inc. has 446 filings in SEC EDGAR's recent list, going back to Jul 12, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Other events
|
Aug 28, 2026 | Aug 28, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Jun 16, 2026 |
| 424B7 | Filing | May 15, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 13, 2026 | May 13, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 16, 2026 |
| EFFECT | Filing | Apr 29, 2026 | — |
| 424B3 | Prospectus | Apr 29, 2026 | — |
| CORRESP | Letter to the SEC | Apr 27, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2026 | — |
| S-3 | Shelf registration | Apr 22, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 1, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| EFFECT | Filing | Mar 19, 2026 | — |
| 424B3 | Prospectus | Mar 19, 2026 | — |
| CORRESP | Letter to the SEC | Mar 17, 2026 | — |
| S-3/A | Filing | Mar 17, 2026 | — |
| S-8 | Employee stock plan registration | Mar 16, 2026 | — |
| CORRESP | Letter to the SEC | Mar 16, 2026 | — |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 16, 2026 | Mar 16, 2026 |
| UPLOAD | Letter from the SEC | Feb 24, 2026 | — |
| S-3 | Shelf registration | Feb 20, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 18, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 29, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Listing notice
|
Jan 23, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Other events
|
Jan 9, 2026 | Jan 9, 2026 |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| EFFECT | Filing | Dec 29, 2025 | — |
| D | Filing | Dec 29, 2025 | — |
| CORRESP | Letter to the SEC | Dec 23, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2025 | — |
| S-3 | Shelf registration | Dec 19, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 9, 2025 | Dec 8, 2025 |
| S-8 | Employee stock plan registration | Dec 8, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Other events
|
Oct 24, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Other events
|
Oct 15, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Other events
|
Sep 8, 2025 | Sep 8, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2025 | Jun 5, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 14, 2025 | May 14, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 5, 2025 |
| 10-K | Annual report | Mar 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Other events
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Other events
|
Feb 5, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Material agreement
|
Nov 8, 2024 | Nov 8, 2024 |
| 424B5 | Prospectus supplement | Nov 8, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Oct 9, 2024 | Oct 9, 2024 |
| S-8 | Employee stock plan registration | Aug 21, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Other events
|
Jun 17, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 424B3 | Prospectus | Apr 30, 2024 | — |
| EFFECT | Filing | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Other events
|
Apr 10, 2024 | Apr 10, 2024 |
| UPLOAD | Letter from the SEC | Apr 8, 2024 | — |
| S-3 | Shelf registration | Apr 3, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Mar 26, 2024 | Mar 26, 2024 |
| 10-K | Annual report | Mar 26, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure, Other events
|
Mar 12, 2024 | Mar 11, 2024 |
| 424B3 | Prospectus | Feb 9, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 6, 2024 | Feb 6, 2024 |
| 424B3 | Prospectus | Feb 5, 2024 | — |
| EFFECT | Filing | Feb 2, 2024 | — |
| 8-K |
Current report
Results of operations
|
Feb 2, 2024 | Feb 2, 2024 |
| CORRESP | Letter to the SEC | Jan 31, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jan 26, 2024 | Jan 26, 2024 |
| S-3 | Shelf registration | Jan 26, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 4, 2024 | Jan 4, 2024 |
| S-8 | Employee stock plan registration | Nov 9, 2023 | — |
| 8-K |
Current report
Results of operations, Other events
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Oct 16, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Other events
|
Oct 13, 2023 | Oct 13, 2023 |
| 8-K |
Current report
Other events
|
Sep 11, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 24, 2023 | Aug 23, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 10, 2023 | Aug 10, 2023 |
| ARS | Annual report to shareholders | Jul 11, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Jul 11, 2023 | Aug 23, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 5, 2023 | Jul 3, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
May 8, 2023 | May 5, 2023 |
| 10-K/A | Amended annual report | Apr 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Auditor change
|
Apr 18, 2023 | Apr 17, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Other events
|
Mar 1, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 24, 2023 | Feb 22, 2023 |
| 424B5 | Prospectus supplement | Feb 24, 2023 | — |
| 424B5 | Prospectus supplement | Feb 22, 2023 | — |
| 8-K |
Current report
Other events
|
Feb 14, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 13, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Other events
|
Feb 10, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 30, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Other events
|
Jan 26, 2023 | Jan 26, 2023 |
| 8-K |
Current report
Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| S-8 | Employee stock plan registration | Dec 15, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Nov 17, 2022 | Nov 16, 2022 |
| 8-K |
Current report
Listing notice
|
Nov 16, 2022 | Nov 15, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| DEF 14A | Proxy statement | Oct 26, 2022 | Nov 16, 2022 |
| PRE 14A | Preliminary proxy statement | Oct 11, 2022 | Nov 16, 2022 |
| 8-K |
Current report
Listing notice
|
Sep 16, 2022 | Sep 12, 2022 |
| 424B5 | Prospectus supplement | Sep 2, 2022 | — |
| 8-K |
Current report
Listing notice
|
Aug 19, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Aug 2, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Listing notice
|
Jul 29, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Listing notice
|
Jul 1, 2022 | Jun 29, 2022 |
| DEF 14A | Proxy statement | Jun 10, 2022 | Jul 28, 2022 |
| S-8 | Employee stock plan registration | Jun 3, 2022 | — |
| PRE 14A | Preliminary proxy statement | May 27, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Listing notice, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
May 17, 2022 | May 16, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 16, 2022 | May 16, 2022 |
| 10-K/A | Amended annual report | May 2, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 15, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2022 | Jan 13, 2022 |
| 8-K |
Current report
Other events
|
Dec 9, 2021 | Dec 8, 2021 |
| S-8 | Employee stock plan registration | Nov 9, 2021 | — |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2021 | Nov 8, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2021 | Oct 13, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Other events
|
Aug 6, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2021 | Jun 9, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| DEFA14A | Additional proxy material | Apr 28, 2021 | — |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 9, 2021 |
| 10-K | Annual report | Mar 16, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2021 | Mar 16, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Other events
|
Dec 28, 2020 | Dec 28, 2020 |
| EFFECT | Filing | Nov 30, 2020 | — |
| CORRESP | Letter to the SEC | Nov 25, 2020 | — |
| S-3/A | Form s-3/a | Nov 24, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2020 | — |
| S-8 | Employee stock plan registration | Nov 12, 2020 | — |
| S-3 | Shelf registration | Nov 12, 2020 | — |
| 10-Q | Quarterly report | Nov 6, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 29, 2020 | Sep 28, 2020 |
| 8-K |
Current report
Listing notice, Officer or director change, Regulation FD disclosure
|
Sep 18, 2020 | Sep 16, 2020 |
| 10-Q | Quarterly report | Aug 11, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2020 | Aug 11, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 29, 2020 | Jun 26, 2020 |
| 10-Q | Quarterly report | May 15, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 15, 2020 | May 15, 2020 |
| DEFA14A | Additional proxy material | Apr 29, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 26, 2020 |
| 8-K |
Current report
Other events
|
Apr 3, 2020 | Apr 3, 2020 |
| 10-K | Annual report | Mar 27, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2020 | Mar 26, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Auditor change
|
Dec 16, 2019 | Dec 10, 2019 |
| S-8 | Employee stock plan registration | Nov 18, 2019 | — |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2019 | Nov 14, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 7, 2019 | Oct 7, 2019 |
| 424B4 | Prospectus | Oct 4, 2019 | — |
| FWP | Free writing prospectus | Oct 3, 2019 | — |
| EFFECT | Filing | Oct 2, 2019 | — |
| S-1MEF | Filing | Oct 2, 2019 | — |
| CERT | Filing | Oct 2, 2019 | — |
| S-1/A | Amended registration statement | Oct 2, 2019 | — |
| CORRESP | Letter to the SEC | Sep 30, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- APRE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Doylestown, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1781983
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.